Price target
371.820.000.00%
The 16 analysts offering 1 year price forecasts for 1MDGL have a max estimate of — and a min estimate of —.
Analyst rating
Based on 17 analysts giving stock ratings to 1MDGL in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
1MDGL EPS for the last quarter is −3.07 EUR despite the estimation of −3.46 EUR. In the next quarter EPS is expected to reach −3.07 EUR. Track more of MADRIGAL PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter MADRIGAL PHARMACEUTICALS INC revenue is expected to reach 137.39 M EUR. Check out MADRIGAL PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, 1MDGL price target is 371.82 EUR with a max estimate of 478.41 EUR and a min estimate of 219.72 EUR. Check if this forecast comes true in a year, meanwhile watch MADRIGAL PHARMACEUTICALS INC stock price chart and keep track of the current situation with 1MDGL news and stock market news.
We've gathered opinions of 17 analysts rating 1MDGL stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.